Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Robert, Overton"'
Autor:
Isaac D. Smith, Theresa M. Coles, Catherine Howe, Robert Overton, Nicoleta Economou‐Zavlanos, Mary J. Solomon, Rong Zhao, Bhargav Adagarla, Jayanth Doss, Ricardo Henao, Megan E. B. Clowse, David L. Leverenz
Publikováno v:
ACR Open Rheumatology, Vol 4, Iss 10, Pp 845-852 (2022)
Objective The purpose of this study was to evaluate a novel scoring system, the Encounter Appropriateness Score for You (EASY), to assess provider perceptions of telehealth appropriateness in rheumatology encounters. Methods The EASY scoring system p
Externí odkaz:
https://doaj.org/article/385d9c2cbe1a4ade9a8c2fdb997398d4
Autor:
Ann Marie Navar, Ahmed A. Kolkailah, Robert Overton, Nishant P. Shah, Justin F. Rousseau, Greg C. Flaker, Michael P. Pignone, Eric D. Peterson
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 22 (2022)
Background Among patients with nonvalvular atrial fibrillation (AF) and an elevated stroke risk, guidelines recommend direct oral anticoagulants (DOACs) over warfarin for stroke prevention. Changes in DOAC use over the past decade have not been well
Externí odkaz:
https://doaj.org/article/85642bbcdc2146d6bf90696bf8410ad9
Autor:
Jamie L. Todd, Richard Vinisko, Yi Liu, Megan L. Neely, Robert Overton, Kevin R. Flaherty, Imre Noth, L. Kristin Newby, Joseph A. Lasky, Mitchell A. Olman, Christian Hesslinger, Thomas B. Leonard, Scott M. Palmer, John A. Belperio, on behalf of the IPF-PRO Registry investigators
Publikováno v:
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) play important roles in the turnover of extracellular matrix and in the pathogenesis of idiopathic pulmonary fibrosis (IPF). This study aimed to determine the
Externí odkaz:
https://doaj.org/article/e7f3bff0a88945d383d884e06a0c2594
Autor:
Jamie L. Todd, Megan L. Neely, Robert Overton, Katey Durham, Mridu Gulati, Howard Huang, Jesse Roman, L. Kristin Newby, Kevin R. Flaherty, Richard Vinisko, Yi Liu, Janine Roy, Ramona Schmid, Benjamin Strobel, Christian Hesslinger, Thomas B. Leonard, Imre Noth, John A. Belperio, Scott M. Palmer, on behalf of the IPF-PRO Registry investigators
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-13 (2019)
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease for which diagnosis and management remain challenging. Defining the circulating proteome in IPF may identify targets for biomarker development. We sought to quantif
Externí odkaz:
https://doaj.org/article/e7e9aa1e37874cbe8ab7871c8f6fedf1
Autor:
Ann Marie Navar, Eric D. Peterson, Michael G. Nanna, Adam J. Nelson, Robert Overton, Karen Chiswell, David F. Kong
Publikováno v:
Atherosclerosis
Background and aims Identifying patient subgroups with cardiovascular disease (CVD) at highest risk for recurrent events remains challenging. Angiographic features may provide incremental value in risk prediction beyond clinical characteristics. Meth
Autor:
Jamie L, Todd, Megan L, Neely, Robert, Overton, Hillary, Mulder, Jesse, Roman, Joseph A, Lasky, Joao A, de Andrade, Mridu, Gulati, Howard, Huang, Thomas B, Leonard, Christian, Hesslinger, Imre, Noth, John A, Belperio, Kevin R, Flaherty, Scott M, Palmer
Publikováno v:
Lung. 200(1)
Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal disease with a variable clinical course. Biomarkers that predict patient outcomes are needed. We leveraged data from 300 patients in the multicenter IPF-PRO Registry to determi
Autor:
Kevin R. Flaherty, Timothy P.M. Whelan, Jesse Roman, Nishant Gupta, David J. Lederer, Yolanda Mageto, Maryl Kreider, Paul Sachs, Hyun J Kim, Joseph A. Lasky, Imre Noth, Ramona Schmid, Sally Suliman, Zeenat Safdar, Mridu Gulati, Christian Hesslinger, Prema Menon, L. Kristin Newby, Robert Overton, Andrew Namen, Leann Silhan, Lake Morrison, Thomas Leonard, John A. Belperio, Marilyn K. Glassberg, Albert Baker, Daniel A. Culver, Scott M. Palmer, Francis Cordova, Rishi Raj, Scott Beegle, Benjamin Strobel, Justin M. Oldham, Mary E. Strek, Tristan J. Huie, Daniel F. Dilling, Jamie L. Todd, Robert J. Kaner, Richard Vinisko, David Hotchkin, Lisa Lancaster, Timothy Liesching, Barry Sigal, Jason Lobo, Kalpalatha Guntupalli, Yi Liu, Megan L. Neely, Joao A. de Andrade, Amy Hajari Case, Doug Lee, Randolph J. Lipchik, Katey Durham, Rajat Walia, Murali Ramaswamy, Tonya D. Russell, Howard J. Huang, Jeremy Tabak, Wael Asi, Rany Condos, Janine Roy
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-13 (2019)
Respiratory Research
Respiratory Research
Background Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease for which diagnosis and management remain challenging. Defining the circulating proteome in IPF may identify targets for biomarker development. We sought to quantify the cir
Autor:
Ahmed A. Kolkailah, Ann Marie Navar, Robert Overton, Nishant Shah, Justin Rousseau, Greg C. Flaker, Michael Pignone, Eric D. Peterson
Publikováno v:
Journal of the American College of Cardiology. 79:25
Autor:
Hyun J Kim, Mridu Gulati, Scott M. Palmer, Christian Hesslinger, Robert Overton, Imre Noth, Justin M. Oldham, Hillary Mulder, Thomas Leonard, Megan L. Neely, Jamie L. Todd
Publikováno v:
Idiopathic interstitial pneumonias.
Background: IPF is characterized by parenchymal accumulation of collagen-rich extracellular matrix (ECM). Circulating collagen neoepitopes reflect ECM turnover. Aim: Determine whether serum concentrations of neoepitopes are associated with disease se
Autor:
Thomas Leonard, Kevin R. Flaherty, Megan L. Neely, John A. Belperio, Scott M. Palmer, Jesse Roman, Christian Hesslinger, Joseph A. Lasky, Imre Noth, Hillary Mulder, J. De Andrade, Robert Overton, Mridu Gulati, Jamie L. Todd, Howard J. Huang
Publikováno v:
D13. ILD PROGNOSIS AND BIOMARKERS II.